News
Is the day of the zombie biotech coming to an end? Eyes have it: Peninsula biotech focuses on glaucoma, more in big test Eyes have it: Peninsula biotech focuses on glaucoma, more in big test © 2025 ...
Scientists at The Jackson Laboratory (JAX) have developed mouse models that survive premature death and enable pre-clinical ...
A new gene therapy trial safely restores hearing in deaf children and adults, offering hope for those with DFNB9 deafness ...
The state-of-the-art technique can improve hearing in children and adults with congenital deafness or severe hearing ...
The state of the art technique can improve hearing in children and adults with congenital deafness or severe hearing ...
ProBio opens a 128,000-sq.-ft. gene therapy facility in Hopewell, creating 110+ jobs and advancing global cell and gene ...
Ferring Pharmaceuticals officially opened doors to its state-of-the-art gene therapy manufacturing facility in Parsippany ...
ProBio, a global contract development and manufacturing organization (CDMO) specializing in cell and gene therapy, today ...
Last month, a baby got the world’s first personalized gene-editing treatment. What will this mean for millions of others with genetic diseases?
A new gene therapy delivery device could let hospital pharmacies make personalized nanomedicines to order. This democratized ...
Cleveland Clinic Children’s Hospital is among the first in the country to use a new gene therapy to treat patients with thalassemia, a genetic blood disorder that affects the ability to produce normal ...
Dr. Omar H. Llaguna, specialist in surgical oncology, programs a HistoSonics medical device for targeting a medium that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results